NEW YORK, NY – WallachBeth Further Expands Healthcare Research Team; Brian Jeep Appointed Lead Pharmaceutical Analyst for Institutional Brokerage New York—April 30, 2014—WallachBeth Capital LLC, a leading provider of institutional healthcare industry research and agency-only execution services for equities, options and exchange-traded products, announced today that Brian Jeep has joined the firm as Lead Pharmaceutical Analyst. Mr. Jeep has worked in and/or covered the pharmaceutical industry since 2001.
During the four years immediately prior to joining WallachBeth, Mr. Jeep was Vice President, Pharmaceuticals Equity Research for Wells Fargo Securities. Previously, Mr. Jeep was with Sidoti & Company, where he served as Lead Analyst / Healthcare Research and focused on small-cap stocks within the Pharmaceuticals, Drug Delivery and Diagnostics sectors. Prior to his Wall Street career, Mr. Jeep was with GlaxoSmithKline from 2001 to 2008, during which time his roles included Operational Excellent Expert, Laboratory Validation Engineer and Chemist. Mr. Jeep holds an MBA from Washington University’s John M. Olin School of Business and a BS in Biology from Rockhurst University.
About WallachBeth Capital LLC
WallachBeth Capital is a leading provider of institutional execution services, offering clients a full spectrum of solutions to help them navigate increasingly complex markets. The firm’s expertise includes ETF and equity trading, derivatives, healthcare research and capital markets. Operating on a fully disclosed, agency-only basis, the firm is committed to facilitating all client needs with transparency and integrity. The firm’s website is located at www.wallachbeth.com.
For media inquiries:
Meghan Callanan
mcallanan@wallachbeth.com
646.412.6012